To study efficacy of Padavas churn in the management of shwetpradar

Randomised control clinical trial to evaluate the efficacy of Padavas churn in the management of shwetpradar wsrleucorrhoea - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093402

Enrollment

Registered

2025-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having symptoms of Shwetapradara i.e. Strava, Yoni Kandu, Katishoola & Daurgandha. 2.Patients between the age group of 18 to 30 years. 3.Married women.

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and more than 30 years. 2.Pregnant women. 3.Lactating women. 4.Patients having known case of Hypertension, Diabetes mellitus, Ca, or any serious systemic disorders. 5.Known case of HIV & STD?s. 6.Patients having pathological conditions like vaginitis, pelvic inflammatory diseases.

Design outcomes

Primary

Measure	Time frame
There is significant effect of Padavas Churna in the management of Shwetapradara w.s.r. to Leucorrhoea.Timepoint: 0,3th,5th,7th	—

Secondary

Measure	Time frame
There is significant effect of Padavas Churna in the management of Shwetapradara w.s.r. to Leucorrhoea.Timepoint: 0,3th,5th,7th	—

Countries

India

Contacts

Public ContactDrPrasad Lomte

Late kedari Redekar ayurvedic mahavidyalaya, Gadhinglaj, kolhapur

prasad.lomte969@gmail.com8275917687

Outcome results